The reviewed record of science sign in
Pith

arxiv: 2210.05274 · v1 · pith:UIOMX4JA · submitted 2022-10-11 · cs.LG · q-bio.BM

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

Reviewed by Pith T0 review T1 audit T2 compute T3 formal T4 kernel pith:UIOMX4JArecord.jsonopen to challenge →

classification cs.LG q-bio.BM
keywords fragmentsmoleculardruglinkermodelatomsd-conditionaldesign
0
0 comments X
read the original abstract

Fragment-based drug discovery has been an effective paradigm in early-stage drug development. An open challenge in this area is designing linkers between disconnected molecular fragments of interest to obtain chemically-relevant candidate drug molecules. In this work, we propose DiffLinker, an E(3)-equivariant 3D-conditional diffusion model for molecular linker design. Given a set of disconnected fragments, our model places missing atoms in between and designs a molecule incorporating all the initial fragments. Unlike previous approaches that are only able to connect pairs of molecular fragments, our method can link an arbitrary number of fragments. Additionally, the model automatically determines the number of atoms in the linker and its attachment points to the input fragments. We demonstrate that DiffLinker outperforms other methods on the standard datasets generating more diverse and synthetically-accessible molecules. Besides, we experimentally test our method in real-world applications, showing that it can successfully generate valid linkers conditioned on target protein pockets.

This paper has not been read by Pith yet.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Demystifying Multimodal Biomolecular Co-design With Intrinsic Geodesic Coupling

    q-bio.BM 2026-06 unverdicted novelty 6.0

    GeoCoupling optimizes temporal couplings between modalities in biomolecular generative models and outperforms synchronous baselines on drug design and protein design tasks.